Literature DB >> 31445463

Macroscopic road safety impacts of public transport: A case study of Melbourne, Australia.

Long T Truong1, Graham Currie2.   

Abstract

Mode shift from private vehicle to public transport is often considered as a potential means of improving road safety, given public transport's lower fatality rates. However, little research has examined how public transport travel contributes to road safety at a macroscopic level. Further, there is a limited understanding of the individual effects of different public transport modes. This paper explores the effects of commuting by public transport on road safety at a macroscopic level, using Melbourne as a case study. A random effect negative binomial (RENB) and a conditional autoregressive (CAR) model are adopted to explore links between total and severe crash data to commuting mode shares and a range of other zonal explanatory factors. Overall, results show the great potential of public transport as a road safety solution. It is evident that mode shift from private vehicle to public transport (i.e. train, tram, and bus), for commuting would reduce not only total crashes, but also severe crashes. Modelling also demonstrated that CAR models outperform RENB models. In addition, results highlight safety issues related to commuting by motorbike and active transport. Effects of sociodemographic, transport network, and land use factors on crashes at the macroscopic level are also discussed.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Keywords:  Conditional autoregressive; Crashes; Negative binomial; Public transport; Safety; Transit

Mesh:

Year:  2019        PMID: 31445463     DOI: 10.1016/j.aap.2019.105270

Source DB:  PubMed          Journal:  Accid Anal Prev        ISSN: 0001-4575


  1 in total

1.  Reduced Road Injuries While Commuting Due to Heavy Snowfall and Ensuing Modal Shifts Among Junior High School Students in Japan.

Authors:  Haruhiko Inada; Jun Tomio; Masao Ichikawa; Shinji Nakahara
Journal:  J Epidemiol       Date:  2021-06-22       Impact factor: 3.809

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.